Filter Results :

Your search for Immune returned 86 reports

Sort by


Global Autoimmune Partnering 2010-2017: Deal trends, players and financials

01 Sep 2017  |  Published by:  CurrentPartnering
Global Autoimmune Partnering 2010 to 2017 provides the full collection of Autoimmune disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.-Trends in Autoimmune partnering deals-Financial deal terms for headline, upfront and royalty by stage of development-Au...

$ 2,995.00

Read More

NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

23 Aug 2017  |  Published by:  GlobalData
SummaryNovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and kap...

$ 250.00

Read More

Neurimmune Holding AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

23 Aug 2017  |  Published by:  GlobalData
SummaryNeurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a fo...

$ 250.00

Read More

MedImmune Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

23 Aug 2017  |  Published by:  GlobalData
SummaryMedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respir...

$ 250.00

Read More

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2017

22 Aug 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2017, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) (Hematologica...

$ 2,000.00

Read More

TapImmune Inc (TPIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

22 Aug 2017  |  Published by:  GlobalData
SummaryTapImmune Inc (TapImmune) is a clinical-stage immuno-oncology company that develops therapeutic and preventative vaccines. The company’s pipeline products include TPIV 200, which is intended for the treatment of ovarian and breast cancers. It combines set of licensed technologies, including p...

$ 250.00

Read More

Immune Pharmaceuticals Inc (IMNP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

22 Aug 2017  |  Published by:  GlobalData
SummaryImmune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerative coli...

$ 250.00

Read More

Immune Design Corp (IMDZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

22 Aug 2017  |  Published by:  GlobalData
SummaryImmune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company develops its product candidates through its ZVex and GLAAS discovery platforms. Its product candid...

$ 250.00

Read More

ImmuneXcite Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

17 Aug 2017  |  Published by:  GlobalData
SummaryImmuneXcite Inc (ImmuneXcite) is a biopharmaceutical company that develops immune-activating anti-tumor biotherapeutics for the treatment of cancer. The company develops monoclonal antibodies by employing its mAbXcite, an immunotherapy platform technology that targets cancer cells for destruc...

$ 250.00

Read More

Global Plasma-derived Immune Inhibitor Market Research Report 2017

10 Aug 2017  |  Published by:  QYResearch
In this report, the global Plasma-derived Immune Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report is segmented into several key Regions, with production, consump...

$ 2,900.00

Read More

Primary Immune Deficiency (PID) - Pipeline Review, H2 2017

08 Aug 2017  |  Published by:  Global Markets Direct
SummaryPrimary Immune Deficiency (PID) - Pipeline Review, H2 2017, provides an overview of the Primary Immune Deficiency (PID) (Genetic Disorders) pipeline landscape.Primary immunodeficiency is defined as weaken immune system, allowing repeated infections and other health problems to occur more easi...

$ 2,000.00

Read More

TapImmune Inc (TPIV) - Financial and Strategic SWOT Analysis Review

07 Aug 2017  |  Published by:  GlobalData
SummaryTapImmune Inc (TapImmune) is a clinical-stage immuno-oncology company that develops therapeutic and preventative vaccines. The companys pipeline products include TPIV 200, which is intended for the treatment of ovarian and breast cancers. It combines set of licensed technologies, including pe...

$ 300.00

Read More

Oncimmune Ltd (ONC) - Financial and Strategic SWOT Analysis Review

07 Aug 2017  |  Published by:  GlobalData
SummaryOncimmune Ltd (Oncimmune) is a biotechnology company that discovers and commercializes technologies for the early detection of cancer. The company develops EarlyCDT, a platform technology for detecting early cancer that measures autoantibodies (immuno-biomarkers) in blood that form early in c...

$ 300.00

Read More

2017-2022 Global and Japan Immune system drugs Market Analysis Report

04 Aug 2017  |  Published by:  Q Y Research Japan
The global Immune system drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD i...

$ 3,085.00

Read More

Global Immune system drugs Detailed Analysis Report 2017-2022

03 Aug 2017  |  Published by:  Detailed analysis Research (QY research brand)
This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Immune system drugs industry.This report splits Immune system dru...

$ 3,250.00

Read More
Total 86 records.